Skip Navigation

Link to  the National Institutes of Health  
The Science of Drug Abuse and Addiction from the National Institute on Drug Abuse Archives of the National Institute on Drug Abuse web site
Go to the Home page
   
Drug Abuse Prevention Research meeting.. details in text2nd National Conference on Drug Abuse Prevention Research:
A Progress Update


This Conference was held at the Omni Shoreham Hotel in Washington D.C., August 9-10, 2001.

Biographies (continued)

 
Nicholas S. Ialongo, Ph.D.
Department of Mental Hygiene
School of Hygiene and Public Health
Johns Hopkins University
3400 North Charles Street
Baltimore, MD 21218
(410) 550-3441
(410) 550-3461 fax
nialongo@jhsph.edu

Dr. Ialongo is Associate Professor in the Johns Hopkins University Bloomberg School of Public Health, Department of Mental Hygiene. He is a child and family clinical psychologist and received his doctoral degree in psychology from Michigan State University. Currently, Dr. Ialongo is Principal Investigator on a federally funded grant to follow up two universal preventive interventions designed to prevent mental health and substance abuse disorders.


Pamela Jumper-Thurman, Ph.D.
Tri-Ethnic Center for Prevention Research
Colorado State University
Fort Collins, CO 80523-7902
(970) 491-0251
(970) 491-0527 fax
pjthurman@aol.com

Dr. Jumper-Thurman, a clinical psychologist, is Research Associate at the Tri-Ethnic Center for Prevention Research, Colorado State University. She is the co-author of the Community Readiness Model. Dr. Jumper-Thurman has extensive experience applying the readiness model and in developing culturally appropriate, community-wide approaches to a variety of social problems in Native American and non-native communities.


Nancy Kaufman, R.N., M.S.
The Robert Wood Johnson Foundation
Route 1 and College Road East
Box 2316
Princeton, NJ 08543
(609) 243-5972
(609) 514-5564 fax
nkaufa@rwjf.org

Ms. Kaufman is Vice-President of The Robert Wood Johnson Foundation. In this position, she develops and oversees grant programs in the areas of substance abuse (including tobacco control), primary care, the health professions, health and behavior, and public health. Ms. Kaufman is a member of NIDA's National Advisory Council on Drug Abuse and the U.S. Department of Health and Human Services Interagency Committee on Smoking and Health.


Kathryn Kavanagh, Ph.D.
Child and Family Center
University of Oregon
2738 NE Broadway
Portland, OR 97232
(503) 282-3662
(503) 282-3808 fax
alliance@hevanet.com

Dr. Kavanagh is Director of Project Alliance, Child and Family Center, University of Oregon. She has conducted family research and intervention programs for more than 20 years. Along with Dr. Thomas Dishion at the University of Oregon, she developed the Adolescent Transitions Program. Dr. Kavanagh's current research focuses on mechanisms of family change and assessment for diverse populations.


Sheppard G. Kellam, M.D.
American Institutes for Research
1000 Thomas Jefferson Street, Suite 400
Washington, DC 20007
(202) 944-5418
(202) 944-5454 fax
skellam@air.org

Dr. Kellam is Senior Research Scientist at the American Institutes for Research and Director of the Center for Integrating Education and Prevention Research in Schools. He is a public health psychiatrist who has helped establish the structure and methods of prevention science and knowledge about early risk factors and their malleability. From 1963 through 1982, Dr. Kellam led the developmental epidemiological prevention and early intervention studies in Woodlawn, an African-American urban community on the south side of Chicago. Since 1983, with the Baltimore City Public Schools and Morgan State University, he has led two generations of population-based, randomized preventive field trials.


Keyona King, M.P.H.
Community Anti-Drug Coalitions of America
901 North Pitt Street, Suite 300
Alexandria, VA 22314
(703) 706-0560, ext. 243
(703) 706-0565 fax
kking@cadca.org

Ms. King is Director of Research for Community Anti-Drug Coalitions of America. She is trained in health science education, community health promotion, and education. Ms. King holds a graduate certificate in drug and alcohol studies.


Ruth L. Kirschstein, M.D.
National Institutes of Health
1 Center Drive
Building 1
Room 126, MSC 0148
Bethesda, MD 20892-0148
(301) 496-2433
(301) 402-2700 fax
rk25n@nih.gov

Dr. Kirschstein was named Acting Director of the National Institutes of Health (NIH) on January 1, 2000. She served as the NIH Deputy Director between November 1993 and December 31, 1999, and also served as the Acting NIH Director between July 1993 and November 22, 1993. Prior to that, Dr. Kirschstein was Director of the National Institute of General Medical Sciences, beginning that appointment on September 1, 1974. A native of Brooklyn, New York, she received her B.A. degree in 1947 from Long Island University and her M.D. degree in 1951 from the Tulane University School of Medicine. Dr. Kirschstein has twice taken part in World Health Organization (WHO) deliberations in Geneva, Switzerland, in 1965 as a member of the WHO Expert Group on International Requirements for Biological Substances and in 1967 as a consultant on problems related to the use of live poliovirus oral vaccine. She has received many honors and awards, including the Presidential Meritorious Executive Rank Award, 1980; election as a Fellow of the Institute of Medicine, 1982; selection by the Office of Personnel Management as 1 of 10 outstanding executives and organizations for its first group of "Profiles in Excellence," 1989; election as a Fellow of the American Academy of Arts and Sciences, 1992; and the Public Service Award from the Federation of American Societies for Experimental Biology, 1993.


Alan I. Leshner, Ph.D.
National Institute on Drug Abuse
National Institutes of Health
6001 Executive Boulevard
Room 5274, MSC 9581
Bethesda, MD 20892-9581
(301) 443-6480
(301) 443-9127 fax
al16m@nih.gov

Dr. Leshner was appointed Director of NIDA in February 1994. NIDA, one of the Institutes within the National Institutes of Health, supports more than 85 percent of the world's research on the health aspects of drug abuse and addiction. Before joining NIDA, Dr. Leshner had been with the National Institute of Mental Health (NIMH) since 1988, holding the position of Deputy Director and then Acting Director. He came to NIMH from the National Science Foundation (NSF), where he held a variety of senior positions focusing on basic research in the biological, behavioral, and social sciences as well as on science education. Dr. Leshner joined the NSF after 10 years at Bucknell University, where he was Professor of Psychology. His research has focused on the biological bases of behavior. Dr. Leshner is the author of a major textbook on the relationship between hormones and behavior and numerous book chapters and papers in professional journals. He received his undergraduate degree in psychology from Franklin and Marshall College and his master's and doctoral degrees in physiological psychology from Rutgers University. Dr. Leshner also holds honorary Doctor of Science degrees from Franklin and Marshall College and the Pavlov Medical University in St. Petersburg, Russia. He has been elected a Fellow of many professional societies and has received numerous awards from both professional and lay groups. In 1996, President Clinton conferred on Dr. Leshner the Presidential Distinguished Executive Rank Award, the highest award in Federal service. In 1998, Dr. Leshner was elected to membership in the Institute of Medicine, National Academy of Sciences.


Mark W. Lipsey, Ph.D.
Center for Evaluation Research and Methodology
Vanderbilt Institute for Public Policy Studies
Vanderbilt University
1207 18th Avenue, South
Nashville, TN 37212
(615) 343-2696
(615) 322-8081 fax
mark.lipsey@vanderbilt.edu

Dr. Lipsey is Professor of Public Policy at Vanderbilt University's Peabody College, where he serves as Co-Director of the Center for Evaluation Research and Methodology at the Vanderbilt Institute for Public Policy Studies. His research focuses on risk, prevention, and intervention for antisocial behavior and issues of methodological quality in program evaluation research.

[More Biographies][Prevention Conference Agenda][Prevention Conference Index]



Archive Home | Accessibility | Privacy | FOIA (NIH) | Current NIDA Home Page
National Institutes of Health logo_Department of Health and Human Services Logo The National Institute on Drug Abuse (NIDA) is part of the National Institutes of Health (NIH) , a component of the U.S. Department of Health and Human Services. Questions? See our Contact Information. . The U.S. government's official web portal